Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12 by Sandhu, Sumit et al.
ARTICLE
Centrosome dysfunction associated with somatic
expression of the synaptonemal complex protein
TEX12
Sumit Sandhu1, Ieng F. Sou2, Jill E. Hunter3, Lucy Salmon3, Caroline L. Wilson3, Neil D. Perkins3,
Neil Hunter 1✉, Owen R. Davies 3,4✉ & Urszula L. McClurg 2✉
The synaptonemal complex (SC) is a supramolecular protein scaffold that mediates chro-
mosome synapsis and facilitates crossing over during meiosis. In mammals, SC proteins are
generally assumed to have no other function. Here, we show that SC protein TEX12 also
localises to centrosomes during meiosis independently of chromosome synapsis. In somatic
cells, ectopically expressed TEX12 similarly localises to centrosomes, where it is associated
with centrosome amplification, a pathology correlated with cancer development. Indeed,
TEX12 is identified as a cancer-testis antigen and proliferation of some cancer cells is TEX12-
dependent. Moreover, somatic expression of TEX12 is aberrantly activated via retinoic acid
signalling, which is commonly disregulated in cancer. Structure-function analysis reveals that
phosphorylation of TEX12 on tyrosine 48 is important for centrosome amplification but not
for recruitment of TEX12 to centrosomes. We conclude that TEX12 normally localises to
meiotic centrosomes, but its misexpression in somatic cells can contribute to pathological
amplification and dysfunction of centrosomes in cancers.
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Maintaining genome integrity is critical for the healthygrowth of somatic cells; consequently, genomeinstability is one of the hallmarks of cancer1. Genome
stability must also be maintained through the germline as
gametes are formed via meiosis. Meiotic cell division relies on
highly complex and synchronised chromosome movements to
achieve homologue pairing and crossing-over. Homologous
chromosome pairs must become linked by crossovers in order to
biorient on the meiosis-I spindle, adding an additional level of
complexity relative to mitotic chromosome congression. This
complexity is reflected in a dedicated meiotic structure called the
synaptonemal complex (SC). This supramolecular protein struc-
ture binds together homologous chromosome pairs and is
essential for the maturation of inter-homologue crossover
recombination events, and thereby fertility2–6. Consequently,
meiotic proteins responsible for this process are highly specialised
and otherwise silenced in somatic cells. However, SC proteins are
aberrantly re-expressed in some cancers defining a subset of the
so-called cancer-testis antigens7. On the basis of their roles in
chromosome structure, and their predicted functional interaction
with the DNA recombination machinery, we reasoned that SC
components could be detrimental to chromosomal stability if
expressed outside of the regulated process of meiosis, and thus
could contribute to the aetiology and progression of cancer. This
study details our investigation into the biology of one of these
proteins, namely TEX12.
Here we show that mammalian SC protein TEX12, previously
identified as a component of the SC central element, localises to
centrosomes during meiosis in males, and upon ectopic expres-
sion in somatic cells. TEX12 can localise to centrosomes inde-
pendently of other SC proteins, and its misexpression in somatic
cells is associated with centrosome amplification through a
mechanism that involves phosphorylation of a single conserved
tyrosine, Y48. Centrosome amplification is reported to be suffi-
cient for oncogenesis8–10, although this premise has been
contradicted11–13, suggesting that oncogenesis induced by cen-
trosome amplification might be context-dependent. However, it is
widely accepted that centrosome amplification is associated with
cancer progression and poorer prognosis14–16. In this manuscript
we demonstrate that aberrant expression of TEX12 is common in
cancer where it is associated with centrosome amplification and
poor prognosis. We further find that stimulation of retinoic acid
receptor signalling is required for ectopic expression of TEX12 in
somatic cells. Thus, we propose a previously unappreciated
localisation for TEX12 and uncover the drivers of its aberrant
expression during tumorigenesis.
Results
TEX12 is aberrantly expressed in cancer cells. Meiotic
machinery can be harnessed by cancer cells to promote
oncogenesis17–21. We analysed large-scale transcriptomic datasets
of patient samples and observed that a synaptonemal complex
protein, TEX12, was aberrantly expressed in a wide variety of
tumours in ~10% of patients (ranging between 5 and 17%) (Suppl
Fig. 1a). Immunofluorescent staining, performed in a number of
cancer cell lines and upon ectopic expression in mitotic cells,
consistently revealed expression of TEX12 in dot-like peri-nuclear
foci (Fig. 1a and Suppl Fig. 2a, b). The number and location of
TEX12 foci resembled that of centrosomes. Accordingly, TEX12
co-localised with pericentrin foci in cancer cells (Fig. 1b, c),
confirming its recruitment to the pericentrosomal area of cen-
trosomes furthermore, we have observed centrosomal TEX12 in
mitosis (Fig. 1d)
Analysis of TEX12 expressing cancer cell lines revealed high
levels of rosette mitoses defined by presence of a centriole rosette
at one or both centrosomes22, a centrosome phenotype
commonly associated with cancer22. Rosettes were substantially
reduced upon TEX12 silencing by siRNA (Fig. 1e), implying a
cause-and-effect relationship. We therefore set out to investigate
if, in keeping with the mechanisms of other meiosis-specific genes
in cancer17,21, the centrosomal role of TEX12 in cancer cells may
represent a pseudo-meiotic function.
TEX12 assembles into toroidal structures at spermatocyte
centrosomes. The localisation of TEX12 to centrosomes in cancer
cells raises the possibility that its physiological function during
meiosis might also include a role at microtubule organising
centres (MTOCs) in addition to its well-established role in
chromosome synapsis. Consistently, in mouse meiotic sperma-
tocytes in early prophase I, TEX12 localised to peri-nuclear dot-
like foci as well as SCs (Fig. 2a and Suppl Fig. 2a). In metaphase-I
nuclei, after the SC disassembles, two prominent
TEX12 structures were present that were no longer restricted to a
peripheral location (Fig. 2b). To address the possibility that these
foci might be centrosome-related structures, spermatocytes were
co-stained for TEX12 and the MTOC marker, γ-tubulin (Fig. 2c).
In prophase-I spermatocytes, two TEX12 foci partially overlapped
with bright γ-tubulin signals (Fig. 2c). During diakinesis/meta-
phase-I, TEX12 toroids appeared to encircle the two brightly
staining γ-tubulin structures (Fig. 2c, ii). Numerous additional γ-
tubulin structures appeared at this time, many of which localised
to centromere regions (that retained residual SYCP3 protein) and
presumably nucleate kinetochore-associated microtubules. In
post MI spermatocytes (that had lost residual SYCP3), two bright
γ-tubulin-staining MTOCs remained, which were closely apposed
and surrounded by interconnected TEX12 toroids (Fig. 2c, iii).
We hypothesise that these structures are the precursors of MII
spindles.
To confirm that TEX12-stained structures were centrosomes,
we immuno-stained mouse spermatocytes for TEX12 and the
core centriole marker Centrin (Fig. 2d). Close juxtaposition of
TEX12 and Centrin signals was observed throughout meiotic
prophase I and metaphase I. In prophase I, TEX12 was localised
peripheral to nuclei as an elongated or bi-lobed structure, two
closely apposed foci, or two more widely separated foci (Fig. 2d,
i–v). Centrin was localised immediately adjacent to these
TEX12 structures, typically appearing as three or four distinct
foci, indicating that centrosome-like MTOCs had been dupli-
cated. During diakinesis/metaphase-I, TEX12 structures morphed
into two internally located toroids, each associated with two
Centrin foci atop these structures (Fig. 2d, v–viii). In some
metaphase-I nuclei, the two TEX12-Centrin structures were
elongated and positioned on either side of the chromosome mass,
with the Centrin foci on the outer, poleward faces (Fig. 2d, viii).
Finally, we showed that TEX12 localises to centrosome-related
structures in the Sycp1 knock-out mutant mouse, which lacks the
SC central region (Fig. 2e), indicating that the localisation of
TEX12 to meiotic centrosomes, and possibly also its function at
these organelles, is independent of its synaptic function. Taken
together, our localisation studies are consistent with TEX12 being
a meiosis-specific component of the outer pericentriolar material
(PCM) where it may augment or replace another PCM factor to
facilitate meiotic spindle function.
Ectopically expressed TEX12 perturbs centrosome homeostasis
in somatic cells. To confirm that TEX12 can incorporate into
centrosomes independently of other SC proteins, we ectopically
expressed TEX12 in somatic cells. FLAG-tagged TEX12 expressed
in COS7 cells, which do not natively express TEX12 (Suppl
Fig. 2a, d), localised to the centrosomes, based on co-staining with
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centrin (Fig. 3a) and pericentrin (Fig. 3b). Furthermore, TEX12
localisation patterns in somatic cells recapitulated the localisation
observed in meiotic cells, with TEX12 colocalizing with pericen-
trin in dot-like foci (Fig. 3b). Thus, we conclude that TEX12 is
recruited to centrosomes in both meiotic and somatic cells
independently of other SC proteins.
Cancers are commonly characterised by centrosome amplifica-
tion and rosette centrosomes that lead to changes in spindle
morphology, asymmetric cell division and genome
instability9,10,15,16,22–25. Thus, given our finding that TEX12
localises to centrosomes, we wondered whether aberrant expres-
sion of TEX12 in cancer cells might promote centrosome
amplification. Consistently, we observed that centrosome num-
ber, determined by counting centrin-staining structures,
increased upon TEX12 overexpression (Fig. 3c), with 33% of
cells that were transfected with TEX12 (15/45) presenting with
more than 2 centrin-staining structures compared to one cell in
the vector only control. Moreover, the intensity of pericentrin
staining per centrosome was significantly increased (Fig. 3d) and
centrosomes appeared larger than those of control cells with the
empty vector as assessed by measuring the diameters of centrin-
staining structures (Fig. 3f). Notably, we observed that TEX12
expression induced a pattern of enlarged and diffuse centrosomal
staining indicative of rosette centrosomes/amplified centrosomes
(Fig. 3e), which have been described as a common feature of
cancer cells16,22,26. Thus, TEX12 is recruited to somatic
centrosomes and promotes alterations in centrosome number
and morphology. However as TEX12 is not the sole driver of
centrosome amplification, silencing its expression in cancer cells
characterised by amplified centrosomes was not sufficient to
restore normal centrosome numbers even though a non-
significant decreasing trend can be observed (Suppl Fig. 1h).
TEX12 forms a stable homodimer in the absence of SC part-
ners. What is the structural basis of the centrosomal recruitment
of TEX12? Within the SC, 2:2 and 4:4 SYCE2:TEX12 complexes
undergo self-assembly into long fibres that are thought to enable
SC growth along the entire length of meiotic chromosomes27–30.
However, SYCE2 was not required for centrosomal localisation of
TEX12 (Fig. 4a, b), raising the question of whether SYCE2-
binding is compatible with TEX12 recruitment to centrosomes.
The isolated expression of SYCE2 in COS7 cells produced a
predominantly cytoplasmic staining pattern (Fig. 4a). However,
co-expression of SYCE2 and TEX12 led to SYCE2 recruitment to
centrosomes (Fig. 4a, b). Thus, whilst TEX12 is recruited to
Fig. 1 TEX12 is a centrosomal protein in cancer. a Cells were stained for TEX12 visible in red with DAPI visible in blue. Bar= 20 µm. b Cells were
stained for TEX12 (red), centrin (green) and nuclei were visualised in blue with DAPI. Arrows indicate centrosomes. Bar= 20 µm. c Cells were stained for
TEX12 (red), pericentrin (green) and nuclei were visualised in blue with DAPI. Arrows indicate centrosomes. Bar= 20 µm. d Dividing PC3 cells stained for
TEX12 visible in red, α-tubulin visible in green and DAPI visible in blue. Bar= 20 µm. e Cancer cells were treated with non silencing control (CTR) siRNA,
siTEX12 B or siTEX12 C for 96 h followed by centrin staining in green. Mitosis types were quantified in 200 cells from three independent experiments.
*p < 0.05; ***p < 0.005. Error bars represent standard deviation.
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Fig. 2 TEX12 localises to centrosomes in mouse meiosis. a Pachytene-stage mouse spermatocyte immuno-stained for chromosome axis marker SYCP3
and TEX12. Individual nuclei are outlined. b Two views of metaphase-I nuclei with SYCP3 and TEX12 staining. c Spermatocyte nuclei at pachytene (i),
diakinesis/metaphase-I (ii) and post-metaphase-I (iii), immuno-stained for SYCP3 (blue), TEX12 (red) and γ-Tubulin (white). Centrosomes are highlighted
with arrowheads and magnified in the lower panels. d Mouse spermatocytes immuno-stained for SYCP3 (blue), TEX12 (red), and centrosomal marker
Centrin (white) (i–vi) or TEX12, Centrin (white) and DAPI (blue) (vii–viii). Individual centrosomes are highlighted with arrowheads and magnified in the
lower panels. For panel (viii), both TEX12-staining structures are magnified below. e Spermatocyte nuclei from an Sycp1 mutant, immuno-stained for
TEX12, Centrin, γ-Tubulin and SYCP3. Centrosome are highlighted with arrowhead and magnified on side. All images are from squash preparations of
mouse spermatocyte nuclei. Scale bar in all images, 10 µm.
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centrosomes in the absence of SYCE2, centrosome-associated
TEX12 retains its ability to bind SYCE2.
In agreement with an SYCE2-independent localisation of TEX12
at centrosomes, we found that recombinant human TEX12 was
soluble and stable in isolation (Fig. 4c and Supplementary Fig. 3a, b).
Analysis by Circular Dichroism (CD) and Size Exclusion Chromato-
graphy Multi-Angle Light Scattering (SEC-MALS) revealed that
TEX12 is a largely α-helical homodimer, with a melting temperature
of approximately 60° C (Fig. 4d and Supplementary Fig. 3c, d).
Further, SEC-MALS and Small-Angle X-ray Scattering (SAXS)
determined that the dimeric structural core is provided by amino-
acids 49–123 (Fig. 4d, e and Supplementary Fig. 3e, f), corresponding
to the same region that interacts with SYCE230. Thus, TEX12 can
adopt alternative conformations of an isolated homodimer or within
2:2, 4:4 and fibrous SYCE2:TEX12 complexes, through the same α-
helical core.
A conserved sequence motif in TEX12 is important for the
centrosome amplification. To pinpoint the molecular determinants
of TEX12 centrosomal recruitment, we generated a series of TEX12
truncation variants based on our biochemical characterisation of its
structural and unstructured regions. We found that the structural
core (49–123) alone was not recruited to centrosomes at the same
rate as full-length protein (Fig. 5a). However, the presence of an
additional four amino-acids at the N-terminal end of the structural
core (45–123) was sufficient to mediate recruitment comparable to
full-length protein. To dissect this further, we analysed C-terminal
truncations of the TEX12 structural core that preserve its unstruc-
tured N-terminus (Fig. 5a). We observed centrosomal localisation for
all C-terminal truncations (expressed proteins correspond to amino-
acid residues 1–113, 1–91 and 1–56) (Fig. 5a). By contrast, and
similar to truncation 49–123, centrosomal localisation was dimin-
ished for TEX12 87–123 and localisation outside of centrosomes was
observed for both constructs. Thus, we conclude that the ability of
TEX12 to efficiently localise to centrosomes is dependent on the
presence of an evolutionarily conserved four amino-acid sequence
motif, 45-GLFY-48 (Fig. 5b), that is not required for its structural
stability as a homodimer (Fig. 4). Whilst full-length TEX12 led to
significant centrosome over-amplification, this effect was not fully
replicated by truncation variants that retained centrosome recruit-
ment, indicating that the full sequence is required for TEX12 func-
tionality at centrosomes (Fig. 5c). To pinpoint its molecular
mechanism of action, we investigated the role of a highly conserved
Y48 residue (Fig. 5b). Mining of public mass-spectrometry datasets
identified TEX12 peptides containing Y48 in the phosphorylated
form from human lymphoma cell lines (Phosphosite; dataset 12495),
suggesting that this might be a functional phosphorylation site. We
applied kinase prediction algorithms to the G45-D56 TEX12 peptide,
which highlighted seven kinases with the predicted ability to phos-
phorylate this site, namely CSK, DDR, EGFR, SRC, SYK, EPH and
TEC, several of which are known oncogenes31–33. Furthermore, all of
these kinases, apart from TEC, are known to play a role in
meiosis34–38. For these reasons, we generated a Y48F TEX12
phospho-null mutant to determine the role of this conserved phos-
phorylation site on the ability of TEX12 to promote centrosome
amplification and increase centrosome size. Whilst the TEX12-Y48F
mutant protein was recruited to centrosomes, it had no effect on
centrosome number or size (Fig. 5d–f). Thus, the Y48 phosphor-
ylation site is important for the centrosomal pathology in TEX12
positive cancer cells.
TEX12 expression is an early event in tumourigenesis. To
validate our inference that TEX12 expression could contribute to
cancer, we examined the biology of TEX12 in tumourigenesis using
mouse models of lymphoma and hepatocellular carcinoma
(Fig. 6a–c). In an Eµ-myc model of MYC-driven B-cell lymphoma39,
TEX12 protein was not detected in the mesenteric lymph nodes of
naïve mice, but was aberrantly expressed in the lymph nodes of all
lymphoma-positive mice, as assessed by immunohistochemistry
(Fig. 6a). Further, high lymph node expression of TEX12 was cor-
related with a more aggressive disease and shortened survival
(Fig. 6b); analogous observations were made in human ovarian and
glioblastoma cancers (Suppl Fig. 1b, c). We also detected TEX12
expression in a diethylnitrosamine (DEN)-induced mouse model of
hepatocellular carcinoma (HCC)40,41 (Fig. 6c), indicating that ectopic
expression occurs in diverse tumour models. Importantly, TEX12
expression was detected as early as 5 weeks following DEN treatment,
with peak levels observed at 40 weeks (Fig. 6c). Detection at the 5
week-stage indicates that TEX12 is expressed at the very early stages
of oncogenesis, prior to the formation of an overt HCC tumour in
mice. This observation highlights potential for TEX12 as an
early diagnostic marker. In assessing how TEX12 expression might
lead to poor prognosis in human cancers, we found that TEX12
expression and gene amplification each predict more aggressive
disease (Suppl Fig. 1b, c).
Our experimental and bioinformatic analysis suggests that TEX12
is a potential driver of cancer progression. To test whether TEX12 is
important for cancer cell growth, we performed siRNA knockdown
of TEX12 in multiple cancer cell lines (Fig. 6d and Supplementary
Fig. 1d, e). In the majority of cell lines tested, TEX12 silencing
abrogated cellular proliferation, with a failure to increase cell
numbers when cultured for a period of up to seven days (Fig. 6d).
In contrast, TEX12-negative PEO1 cancer cells and non-transformed
fibroblasts were not affected by TEX12 silencing (Fig. 6d), ruling out
off-target effects of siRNA treatment. We further confirmed that this
proliferative defect was not simply due to cell death but due to a G2/
M cell cycle arrest (Supplementary Fig. 1f, g), establishing that TEX12
is required for cell proliferation in a subset of human cancers. These
findings suggest a pro-oncogenic function of TEX12 in a subgroup of
cancers.
Ectopic expression of TEX12 is regulated by retinoic acid sig-
nalling. Aberrant expression of TEX12 in somatic cells con-
tributes to increased proliferation and centrosomal aberrations,
both common features of cancer (Figs. 3 and 6). Previously, it has
been proposed that aberrant expression of meiotic
X-chromosome genes in cancer is driven by genome-wide DNA
demethylation42. To investigate if the same mechanism is true for
TEX12 expression, TEX12-negative U2OS osteosarcoma cells
were subject to chemical demethylation using 3 µM 5-azacytydine
for 48 h43,44. These experiments showed that demethylation alone
was not able to activate ectopic TEX12 expression (Fig. 7a).
Reciprocally, silencing the ten eleven translocation (TET1-3)
demethylating enzymes for 72 h in TEX12-positive PC3 prostate
cancer cells was not sufficient to suppress TEX12 expression
(Fig. 7b). However, 48 h of treatment with retinoic acid, a key
activator of the meiotic programme45, successfully activated
TEX12 expression in somatic cells (Fig. 7a). We used bioinfor-
matics to predict the TEX12 promoter region of chr11:
112,167,162-112,167,382, which was cloned into a luciferase-
reporter vector. A luciferase reporter assay confirmed that this
region contains a promoter element that is activated by retinoic
acid treatment (Fig. 7c). Finally, we assessed which retinoic acid
receptors could play a role in TEX12 expression. Whilst silencing
of any retinoic acid receptor decreased retinoic-acid induced
TEX12 protein levels, TEX12 was strongly diminished only upon
silencing of the retinoic acid receptor B (RARB) or retinoid X
receptor G (RXRG) (Fig. 7d). This observation was confirmed in
PC3 cells, in which RARB was similarly found to be critical for
TEX12 protein expression (Fig. 7e). Upstream of TEX12 there are
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seven RARE sequences including a DR10 supporting the role of
RARs in TEX12 expression. Our data demonstrate that ectopic
expression of TEX12 in somatic cells is activated by retinoic acid
signalling (Fig. 7c) and implicate RARB in this process as it was
the only receptor which played a role in both cell line models
tested (Fig. 7d–g).
Discussion
Increasing evidence implicates mis-expression of meiotic genes
as one of the causes of oncogenic progression, likely through
the promotion of genetic instability and disturbance of genome
maintenance pathways in cancer cells46–50. Here we report
that meiotic synaptonemal complex protein TEX12 is frequently
Fig. 3 TEX12 regulates centrosome division. a, b COS-7 cells were transfected with pCMV-HA-TEX12-FLAG for 48 h following by staining for TEX12
(Abcam ab122455) (red) and centrin or pericentrin (green). Bar= 20 µm. c Centrosome numbers in COS-7 cells 96 h after transfection with TEX12
(n= 45) or empty vector (n= 62) were counted in three independent experiments. ***p < 0.005. d COS-7 cells were transfected with empty vector control
(EV) or TEX12 for 96 h followed by TEX12 and pericentrin imaging. Average pericentrin intensity per centrosome was quantified for 10 cells in each group.
*p < 0.05. e COS-7 cells were transfected with either empty vector or TEX12 for 96 h followed by centrin staining in green. Mitosis types were quantified in
100 cells from three independent experiments. *p < 0.05; ***p < 0.005. f Centrosome size (µm) in COS-7 cells 96 h after transfection with TEX12 or empty
vector was quantified in 10 cells in four independent experiments. **p < 0.01. c–f error bars represent standard deviation.
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mis-expressed in cancer. We also show that TEX12 has a pre-
viously overlooked localisation to the microtubule organising
centres, in both meiosis and mitosis. Our data suggests that at
these locations, TEX12 might promote stabilisation of pericentrin
and centrosome amplification, which is driven by phosphoryla-
tion of a single conserved tyrosine.
What drives TEX12 re-expression in cancer? It is possible that
re-expression of X-chromosome located meiotic genes in cancer
is regulated primarily by demethylation similarly to
X-chromosome reactivation during early development. This has
been previously proposed for MAGE-142,44,51, and the SSX gene
family52. However, epigenetic changes between autosomes and
sex-chromosomes are regulated differently during
spermatogenesis53 where autosomal genes often require deposi-
tion of bivalent epigenetic marks for transcriptional silencing
post-meiosis53. We propose that divergent regulation of expres-
sion between X and autosomal genes could hold true in oncogenic
re-expression. It has been previously reported that demethylation
was unable to consistently induce expression of chromosome 6
located RAGE-143. Similarly, we observed that demethylation
alone was not the driver mechanism of TEX12 re-expression;
however, expression was activated via retinoic acid signalling.
Furthermore, induction of TEX12 re-expression following reti-
noic acid stimulation is of therapeutic relevance as retinoid
treatment is used in oncology54,55 to force cancer cell differ-
entiation, thereby reducing their stemness56. Our results suggest
that this therapeutic approach should be closely evaluated, as
long-term doses of RA may cause ectopic expression of meiotic
proteins, such as TEX12, potentially contributing to centrosome
amplification and other cellular aberrations.
TEX12 is an essential structural component of the central element
of the synaptonemal complex, which mediates chromosome synapsis
in meiosis27. Here, we report a localisation for TEX12, independent
of the SC, within centrosomes of meiotic and cancer cells. During
meiosis, SC assembly is initiated at recombination sites and facilitated
by telomere-led rapid chromosomal movements, mediated by
microtubules associated with the nuclear envelope, and by the bou-
quet configuration, in which telomeres cluster and are constrained
Fig. 4 TEX12 forms a stable α-helical dimer and can localise to centrosomes independently of its SC partner, SYCE2. a COS-7 cells were transfected
with SYCE2 and TEX12 as indicated. Cells were stained for SYCE2 (red) and pericentrin (green). Nuclei were visualised in blue with DAPI. Bar= 20 µm.
b COS-7 cells were transfected with SYCE2 and TEX12 as indicated. Cells were stained for TEX12 (red) and pericentrin (green). Nuclei were visualised in
blue with DAPI. Bar= 20 µm. c Sequence analysis of human TEX12 demonstrating the presence of a core α-helical region in the C-terminal half of the
protein. Secondary structure prediction is shown as per residue scores and protein constructs are indicated along with their sequence boundaries. d SEC-
MALS analysis of TEX12 and TEX12core in which light scattering (LS) and differential refractive index (dRI) are overlaid, with and fitted molecular weights
(Mw) plotted as diamonds across elution peaks. TEX12 and TEX12core are both dimeric, with molecular weights of 27 kDa and 17 kDa, respectively
(theoretical dimer sizes − 28 kDa and 18 kDa). e SEC-SAXS analysis of TEX12 and TEX12core. P(r) distributions of TEX12 (solid line) and TEX12core
(dashed line) showing maximum dimensions of 110 Å and 63 Å, respectively.
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near the microtubule organizing center (MTOC) in mouse
spermatocytes57. This dramatic chromosome choreography suggests
a requirement for close functional integration between the SC and
MTOCs. Given that both the SC and MTOC are coiled-coil rich, a
structural connection between the SC and MTOCs through a shared
coiled-coil protein constituent, such as TEX12, may underlie their
close functional relationship. TEX12 localisation to centrosomes has
similarities with previous observations in which SC components were
found to localise to MTOCs/spindle-pole bodies, including 6C6 in
plants58, and Sme4 in Sordariales59,60. However, this is the first report
Fig. 5 G45-D56 region of TEX12 regulates centrosomal localisation and function. a COS-7 cells transfected with TEX12 plasmids as indicated and stained
with TEX12 (Abcam ab122455) (red) and centrin (green). Centrosomes are indicated with white arrows. Bar= 20 µm. b Diagram of TEX12 domain
structure and comparison of region conservation across species. c Number of centrosomes per cell in COS-7 cells following transfection with indicated
TEX12 plasmids. *p < 0.05; **p < 0.001; ***p < 0.005. Error bars represent standard deviation. Each data point represents an individual cell, between 5 and
15 cells per transfection were measured over three independent experiments. d COS-7 cells were transfected with wild-type (WT) and Y48F TEX12 mutant
as indicated. Bar= 20 µm. e Centrosome size in COS-7 cells 96 h after transfection with WT TEX12 (n= 5) or Y48F TEX12 (n= 5) was quantified.
**p < 0.01. Error bars represent standard deviation across three independent experiments. f Number of centrosomes per cell in COS-7 cells following
transfection with WT or Y48F TEX12 ****p < 0.001. Error bars represent standard deviation. Each data point represents an individual cell, between 5 and 15
cells per transfection were measured over three independent experiments, this is an expansion of e.
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of centrosomal/MTOC localisation of a mammalian SC component.
Thus, our findings suggest a possibility for an evolutionarily con-
served cross-talk between structural components of the mammalian
SC and MTOCs.
Materials and methods
Antibodies and plasmids. The anti-TEX12 (ab122455), anti-pericentrin
(ab28144), anti-gamma tubulin (ab191114), anti-centrin 1 and 2 (ab11257) and
anti-SYCE2 (ab107745) antibodies were obtained from Abcam and anti-FLAG
(F1804) antibody was purchased from Sigma. Human TEX12 sequences,
Fig. 6 TEX12 is expressed with the onset of cancer and is required for cancer cell proliferation. a Eµ-Myc lymphoma and healthy controls mesenteric
lymph nodes were stained and scored for TEX12 protein levels. Each data point indicates one animal (n= 11). Black lines indicate 50 µm. **p < 0.01. Error
bars represent standard deviation. b Kaplan–Meier survival curve of Eµ-myc lymphoma mice divided based on their lymph node TEX12 protein histoscore.
(n= 11). 95% confidence intervals are indicated with dotted lines. c Mice have been scored for liver TEX12 protein levels following DEN-treatment tumour
induction. Each data point represents one animal (n= 22). Error bars represent standard deviation. d Cells were treated with control siRNA (CTR) or two
TEX12 targeting sequences A or B (details in Methods section) and cell growth was measured in three independent experiments every 3 h with IncuCyte.
*p < 0.05; **p < 0.001; ***p < 0.005. Data are presented ±SEM.
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Fig. 7 TEX12 re-expression is not regulated by demethylation but by retinoic acid signalling. a U2OS cells were left untreated or treated with 3 µM
5-azacytidine (5-AZA) or 1 µM retinoic acid. Bar= 20 µm. b PC3 cells were treated with siRNA as indicated. Bar= 20 µm. c HEK293T cells untransfected
(CTR) or transfected with the increasing quantity of pGL4-TEX12 (221 bp) (as indicated by the triangle) or pGL4-SCR plasmid. Luciferase (Luc) activities
were normalised to 1 µg plasmid NT. All data is shown as mean of normalised luciferase activities ± SD of three independent experiments and significant
differences between each group were determined by student’s paired t-test (**p < 0.01, ns= not significant). d U2OS cells treated with or 1 µM retinoic
acid and siRNA as indicated with corresponding quantification. NT non treated. TEX12 intensity measured in 10 cells per condition from three independent
experiments. Bar= 20 µm. e PC3 cells treated with siRNA as indicated. Bar= 20 µm. f U2OS cells treated with or 1 µM retinoic acid and siRNA as indicated
with corresponding quantification. g PC3 cells treated with siRNA as indicated.
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corresponding to amino acids 1–123 (full length) and 49–123 (core) and 45–123,
1–113, 1–91, 1–56 and 87–123, and SYCE2 were cloned into the pCMV-HA vector
(Addgene Catalogue no 631604) for mammalian expression with an N-terminal
FLAG-tag.
Cell culture, transfections and lentiviral transductions. LNCaP and PC3
prostate cancer, MCF7 and MX1 breast cancer, WM1361 NRAS mutant and
WM164 BRAF mutant melanoma, 3T3-L1 mouse fibroblasts and COS-7 cells were
obtained from American Type Culture Collection (Manassas, USA). LNCaP, PC3
and MX-1 cells were maintained in RPMI 1640 media and remaining cell lines in
DMEM media supplemented with 2 mM L-glutamine (Invitrogen) and 10% (v/v)
fetal calf serum (FCS) at 37 °C in 5% CO2. Cell lines were never maintained for
more than 30 passages or 2 months of continuous culturing. Cell lines were tested
for mycoplasma on a tri-monthly basis. Proliferation was measured by live cell
imaging with the Incucyte system every 6 h for 156 h post-treatment. Transfections
were performed using Lipofectamine2000 reagent (Invitrogen) following the
manufacturer’s instructions.
siRNA gene silencing and gene expression analysis. The TEX12 targeting
siRNA sequences were (A) AAGCCUUGGAGAAAGAUUUAAAU[dTdT], (B)
CAGCAGUAGAUGCAUCUUACA[dTdT] and (C) SASI_Hs01_00169803
(Sigma). Cells were reverse transfected with siRNA using RNAiMax (Invitrogen)
according to manufacturer’s instructions and incubated in culture media for 96 h
prior to cell lysis and analysis. For real-time qPCR, total RNA was extracted using
TRIzol (Invitrogen, 15596-026), RNA quality and yields were assessed using a
NanoDrop 2000 (NanoDrop), 1 μg of total RNA was reverse transcribed using
SuperScript VILO (Invitrogen, 11755-050) and qPCR performed using QuantiTect
SYBR Green (QIAGEN, 204143) on an ABI PRISM 7500 Sequence Detection
System (Applied Biosystems). Data was tested for parametric distribution. Para-
metric data was analysed using appropriate t-tests or ANOVA with Bonferroni’s
comparison test for multiple group comparisons. Non-parametric data was ana-
lysed using Wilcoxon signed-rank test. By convention, ***p-values < 0.001,
**p-values < 0.01 and *p-values < 0.05.
Immunohistochemistry. Antigens were retrieved by microwaving the slides in
10 mM citrate pH 6.0 for 15 min followed by staining the tissues. Antibodies were
detected with ImmPRESS HRP IgG (Vector labs). Samples were scored blind using
the histoscore methodology61,62. Briefly, percentage and intensity of staining for
positive cells was estimated (0, 1, 2, 3) using the following equation: H-score= (%
of cells with low level positivity)+ 2 × (% of cells with medium level positiv-
ity)+ 3 × (% of cells with high level positivity). For survival analysis, high marker
levels were defined as a value in the third and fourth upper quarter of the
population.
Immunofluorescence. For Immunofluorescence, cells were fixed for 10 min in ice
cold methanol followed by blocking in 1% BSA, staining for 1 h at room tem-
perature in primary antibodies then for 1 h at room temperature with goat anti-
rabbit Alexa Flour594 (A32740) and rabbit anti-mouse Alexa Fluor488 (A-11059)
Life Technologies secondary antibodies at 1:250 dilution and DAPI, mounting in
prolong antifade gold reagent (Life Technologies P36961) and imaging using LSM
780 confocal microscope and processed with Zen 2.6 blue edition software. For
measuring staining intensity the centrosome area was marked out and the average
pericentrin fluorescence intensity was measured within that area as previously
described63.
Flow cytometry. Cell cycle stage assessment cells were fixed in 70% ethanol and
frozen at −20 °C for at least 24 h prior to staining and flow cytometry which were
performed using Cell Cycle analysis Kit from Guava (Millipore, 4500-0220) and
analysed in a Guava® easycyte HT (Millipore) cytometer as per manufacturers
instructions.
Mouse models. In order to induce liver cancer, day old 15 wild-type mice were
given 30 mg/kg DEN in 0.9% saline by IP injection. Cohorts of mice were
humanely killed, and liver tissue was harvested at various time-points (5 weeks,
20 weeks, 30 weeks and 40 weeks) post DEN administration. Eμ-Myc mice39 were
purchased from The Jackson Laboratory, Maine, USA and wild-type (C57Bl/6)
were purchased from Charles River, UK. Colonies were established and maintained
in the Comparative Biology Centre, Newcastle University, according to the
FELASA Guidelines. No blinding of groups in mouse studies was performed. All
mice were designated to an experimental group dependent on their genotype. To
perform survival analysis, Eμ-Myc transgenic male mice were monitored daily and
were sacrificed at pre-determined end-points, defined as the animal becoming
moribund, losing bodyweight/condition and/or having palpable tumour burden at
any lymphoid organ site. At this point, mice were necropsied and samples taken for
downstream analysis.
All animal experiments were approved by Newcastle University’s Animal
Welfare and Ethical Review Board. All procedures, including the breeding of
genetically modified, Eμ -myc mice, were carried out under project and personal
licences approved by the Secretary of State for the Home Office, under the United
Kingdom’s 1986 Animal (Scientific Procedures). All breeding was undertaken
according to FELASA guidelines.
Spermatocyte staining. Testis were dissected from freshly sacrificed mice and
processed for cell squashes as previously described. This project was conducted in
accordance with the ILAR Guide for the Care and Use of Laboratory Animals and
the UC Davis Animal Welfare Assurance on file with the US Public Health Service,
under the approval and surveillance of the UC Davis Institutional Animal Care
Committee. Briefly, seminiferous tubules were fixed in freshly prepared 2% for-
maldehyde containing 0.1% Triton-X for 10 mins at room temperature. Small
pieces of tubules were placed on a glass slide, minced gently and then squashed
under a coverslip with pressure from the blunt end of pencil. Slides were then
frozen briefly in liquid nitrogen and coverslips removed. Following three washes
with PBS, immunofluorescent staining was performed as described, using the
following primary antibodies with incubation overnight at room temperature:
rabbit anti-TEX12 (Abcam, ab122455;1:200 dilution), mouse anti-Centrin 1
(Millipore, 04-1624; 1:200 dilution), mouse anti-SYCP3-488 (Abcam, ab205846;
1:100 dilution), mouse anti-γ-Tubulin-647 (Abcam, ab191114; 1:100 dilution).
Goat secondary antibodies were then added for 1 h at 37° C, either anti-rabbit 488
(Life Technologies, 31822; 1:1000 dilution), or anti-mouse 594 (Life Technologies,
A-11032, 1:1000 dilution). Finally, slides were rinsed, stained with DAPI and
mounted with ProLong Gold antifade reagent. Images were acquired using a Zeiss
AxioPlan II microscope, ×63, 1.4 NA objective and X-Cite light source. Images
were captured by a Hamamatsu ORCA-ER CCD camera and processed using
Volocity (PerkinElmer).
Recombinant protein expression and purification. Human TEX12 sequences,
corresponding to amino acids 1–123 (full length) and 49–123 (core), were cloned
into the pMAT11 vector64 for bacterial expression as a fusion protein to an
N-terminal His6-MBP-tag, separated by a tobacco etch virus (TEV) site for tag
cleavage. Proteins were expressed in BL21(DE3) E. coli cells (Novagen®), cultured
in 2xYT media and induced with 0.5 mM IPTG at 25° for 16 h. Cells were lysed in
20 mM Tris pH 8.0, 500 mM KCl, by sonication and clarified lysate was applied to
Ni-NTA resin (Qiagen) followed by amylose resin (NEB). Proteins were further
purified by TEV protease cleavage for tag removal, anion exchange (GE Health-
care) and stored at −80 °C in 20 mM Tris pH 8.0, 150 mM KCl, 2 mM DTT after
concentration (PALL Microsep™ Advance, 3kD) to 6-12 mg/ml. Proteins were
analysed by SDS-PAGE (NuPAGE Bis-Tris system) with SimplyBlue SafeStain
(Invitrogen). UV spectrophotometry (Cary 60 UV-Vis, Agilent Technologies) was
used to calculate protein concentrations with theoretical molecular weights and
extinction coefficients determined by ExPASY ProtParam.
Circular dichroism (CD) spectroscopy. CD data were collected using a Jasco
J-810 spectropolarimeter (Institute for Cell and Molecular Biosciences, Newcastle
University). CD spectra for TEX12 and TEX12Core were collected in 10 mM
NaH2PO4 pH 7.5, 150 mM NaF, at 0.36 and 0.24 mg/ml, respectively. Measure-
ments were recorded at 4 °C between 260 and 185 nm, with 0.2 nm intervals, in a
0.2 mm pathlength quartz cuvette (Hellma). Nine measurements were collected
and averaged, with buffer correction, and converted to mean residue ellipticity
(MRE [θ]). The DichroWeb server (http://dichroweb.cryst.bbk.ac.uk) was used for
used for deconvolution with the CDSSTR algorithm. CD thermal melts were
recorded in 20 mM Tris pH 8.0, 150 mM KCl, 2 mM DTT, at 222 nm with a
temperature range of 5-95 °C and a 1 °C per minute ramping rate. Data were
plotted as % unfolded after conversion to MRE ([θ]222,x-[θ]222,5)/([θ]222,95-[θ]222,5),
with melting temperatures (Tm) determined by the temperature at which the
sample is 50 % unfolded.
Size-exclusion chromatography multi-angle light scattering (SEC-MALS).
SEC-MALS was performed to determine the absolute molecular masses of TEX12
and TEX12Core. Protein samples, at 12 and 4 mg/ml, respectively, were loaded onto
a pre-equilibrated (20 mM Tris pH 8.0, 150 mM KCl, 2 mM DTT) Superdex™ 200
Increase 10/300 GL SEC column (GE Healthcare) with an ÄKTA™ Pure (GE
Healthcare) at 0.5 ml/min. The column flow-through was directed to a DAWN
HELEOS II MALS detector (Wyatt Technology) and then to an Optilab T-rEX
(Wyatt Technology) differential refractometer. ASTRA® 6 software (Wyatt Tech-
nology) was used calculate molecular weights from the eluted peaks, by Zimm plot
extrapolation using a 0.1850 ml/g dn/dc value.
Size-exclusion chromatography small-angle X-ray scattering (SEC-SAXS).
SEC-SAXS data collection was carried out at the B21 beamline at the Diamond
Light Source synchrotron facility (Oxfordshire, UK). TEX12 and TEX12Core, at 12
and 6 mg/ml, respectively, were loaded onto a pre-equilibrated (20 mM Tris pH
8.0, 150 mM KCl, 2 mM DTT) Superdex™ 200 Increase 10/300 GL SEC column
(GE Healthcare) with an Agilent 1200 HPLC system at 0.5 ml/min. The column
flow-through was directed to the experimental cell for SAXS data collection in 3 s
frames, with a 4.014 m detector distance at 12.4 keV. ScÅtter 3.0 (http://
www.bioisis.net) was used to analyse SAXS data. Data were subtracted for buffer,
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and then averaged for Guinier (Rg) and cross-sectional radius (Rc) analysis. P(r)
distributions were generated using PRIMUS65.
Statistics and reproducibility. All data was first tested for parametric distribution
and analysed with GraphPad PRISM software. Parametric data was analysed using
appropriate t-tests or ANOVA with Bonferroni’s comparison test for multiple
group comparisons. Non-parametric data was analysed using Mann–Whitney or
Wilcoxon signed-rank test. By convention, ***p-values < 0.001, **p-values < 0.01,
and *p-values < 0.05. Number of experiments is indicated for each figure where
experiments with internal replicates are shown ±SEM while experiments were that
was not possible, e.g. animal work, are shown ±SD.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data and source data and raw blots has been made available in supplementary Fig. 4
and Supplementary data 1 files. All other information are available from the
corresponding author on reasonable request.
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